<DOC>
	<DOCNO>NCT00290914</DOCNO>
	<brief_summary>The purpose evaluate safety usefulness investigational drug , vilazodone depression .</brief_summary>
	<brief_title>Safety Efficacy Study Vilazodone Discovering Genetic Markers Associated With Response Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Male female patient 1865 year age , inclusive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>